Evidence map›Paper›PMID 38292787›Full record

ArticleRadiology case reports2024

Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review.

Amrit Bhusal, Suraj Kc, Tek Nath Yogi, Rakesh Kumar Gupta, Abhijeet Kumar, Bhawani Khanal, Shailendra Katwal, Durga Neupane, Samikshya Lamichhane, Ranjan Bhagat

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amrit BhusalDepartment of Radio-diagnostics and Imaging, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Suraj KcDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Tek Nath YogiBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Rakesh Kumar GuptaDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Abhijeet KumarDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Bhawani KhanalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Shailendra KatwalDepartment of Radiology, Dadeldhura Subregional Hospital, Dadeldhura, Nepal.
Durga NeupaneDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Samikshya LamichhaneDepartment of Radio-diagnostics and Imaging, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Ranjan BhagatDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
B.P. Koirala Institute of Health Sciences · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.

Indexed as

Case reportGastrointestinal stromal tumorsImatinib MesylateMetastasisRareRectal tumors

Identifiers

PMID38292787
PMCPMC10827547
OpenAlexW4390927728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.